This instrument contains a number of concrete features that can create operational risk or unexpected outcomes for the named payors and for advisors dealing with APRA charges. Those features are embedded in the instrument’s precise wording.
Non‑refundable charges: Both fixed amounts in the Schedule are expressly described as non‑refundable. That means once the listed entity has paid the fee under this instrument, the instrument itself disclaims any refund right. No conditions or exceptions for refund are stated. Legal or commercial arguments for recovery would therefore have to proceed outside the instrument.
GST inclusive amounts: The Schedule states the amounts are "inclusive of GST". That fixes the payable dollar figure as final on its face. Parties should not assume that an additional GST component will be added to the listed figure. For accounting purposes, the inclusive phrasing determines the gross cash outlay.
Invoice timing discretion: The Schedule provides that "The invoice may be issued at any time after the date of this instrument." APRA therefore controls when the invoice is sent and can, in principle, issue it immediately or much later. Once APRA issues an invoice, the payor has 14 days to pay. The combination means there can be uncertainty over when the 14‑day period will run and therefore uncertainty as to cashflow planning if APRA delays invoicing.
Short payment window: Payment is due within 14 days of receipt of the invoice. That is a short period for arranging payment of a large, non‑refundable charge (the stated amounts are $309,100 and $130,900 respectively). Failure to have internal processes prepared to meet that window could lead to late payment.
Entity naming specificity: The Schedule lists specific legal entities by name. Payment obligations rest on those named entities. If a legal entity receives an invoice but is not the exact entity named in the Schedule, that may raise a dispute over legal obligation. Corporate groups should check whether the legal entity name on APRA’s invoice matches the entity named in the Schedule. The instrument does not provide a mechanism for APRA to amend a payor name within the instrument.
No stated enforcement mechanism in the instrument: The instrument does not state penalties, late interest, or enforcement steps. That can create uncertainty about consequences of non‑payment, and it does not provide guidance on whether APRA will treat non‑payment as regulatory non‑compliance or merely a contractual debt. Entities should not assume there are no consequences; rather the instrument simply does not detail them.
No procedural or review rights provided: The Schedule and instrument do not outline objection, remission, or dispute procedures. The lack of an internal process in the instrument means any challenge will depend on external legal avenues or on APRA’s general administrative processes, neither of which are articulated here.
Single financial year label but no expiry clause: The instrument title references the financial year 2016-17. The instrument itself, however, does not contain an express expiry clause or retrospective limitation other than its subject matter and commencement by registration. Parties should confirm whether APRA intends the charge as a one‑off for that year and verify whether subsequent instruments have been made for later years.
Potential mismatch between statutory power and practice: The instrument records the delegate’s exercise of power under paragraph 51(1)(a) and (b) of the APRA Act. Any party wishing to challenge the lawfulness of the charge would need to scrutinise whether the power was validly exercised and whether the delegate had authority, but the instrument itself records only that the delegate acted under those paragraph references.
In practice, these "gotchas" boil down to: non‑refundability, APRA’s invoice timing, short payment window, entity naming precision, and absence of procedural protections in the instrument itself. Each is grounded in the literal text of the Schedule and Interpretation clauses.